Document Detail


Novel pharmacologic therapies in development for acute decompensated heart failure.
MedLine Citation:
PMID:  23314727     Owner:  NLM     Status:  In-Data-Review    
Abstract/OtherAbstract:
Acute heart failure is a public health issue with morbidity and mortality exceeding that of myocardial infarction. Novel compounds for the treatment of acute heart failure are clearly needed and fall into the general categories of inotropic, vasodilatory and other compounds in phase I to III of development. Furthest along are omecamtiv mecarbil (a cardiac myosin activator), ularitide (a natriuretic and diuretic peptide) and relaxin (a vasodilator). Each compound has a unique set of assets and liabilities that will aid in the understanding of the syndrome and application to the right patients at the right time in this heterogeneous syndrome. This review will explore current and future novel pharmacologic therapies for the treatment of acute heart failure.
Authors:
Justin A Ezekowitz
Related Documents :
18355507 - Sodium-hydrogen exchange inhibition by cariporide to reduce the risk of ischemic cardia...
15803447 - On the prediction and prevention of myocardial infarctions: models based on retrospecti...
11736957 - The -1185 a/g and -1051 g/a dimorphisms in the von willebrand factor gene promoter and ...
6323097 - Equilibrium radionuclide ventriculography in men after transmural myocardial infarction.
11228087 - Refractory no-reflow successfully treated with local infusion of high-dose adenosine an...
16022967 - Characterization of beta3-adrenoceptors in human internal mammary artery and putative i...
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Current cardiology reports     Volume:  15     ISSN:  1534-3170     ISO Abbreviation:  Curr Cardiol Rep     Publication Date:  2013 Feb 
Date Detail:
Created Date:  2013-01-14     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  100888969     Medline TA:  Curr Cardiol Rep     Country:  United States    
Other Details:
Languages:  eng     Pagination:  329     Citation Subset:  IM    
Affiliation:
Mazankowski Alberta Heart Institute, Edmonton, Alberta, Canada, justin.ezekowitz@ualberta.ca.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The Evolution of the Papanicolaou Smear.
Next Document:  Improving the chemical shift dispersion of multidimensional NMR spectra of intrinsically disordered ...